Kevin Houston

Kevin Houston

Auto-generated profile, based on publicly available information

Kevin Houston

Division of Gastroenterology, Virginia Commonwealth University, Richmond, VA 23298, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
TWTao Wang
Tao Wang
ACAlexis Cunningham
Alexis Cunningham
ADAyotunde O. Dokun
Ayotunde O. Dokun
SHSurovi Hazarika
Surovi Hazarika
KHKevin Houston
Kevin Houston
BABrian H. Annex
Brian H. Annex
Objective—: Surgical hindlimb ischemia (HLI) in mice has become a valuable preclinical model to study peripheral arterial disease. We previously identified that the different phenotypic outcomes after HLI across inbred mouse strains is related to a region on the short arm of mouse chromosome 7. The gene coding the interleukin-21 receptor (IL-21R) lies at the peak of association in this region. Approach and Results—: With quantitative real-time polymerase chain reaction, we found that a mouse strain with a greater ability to upregulate IL-21R after HLI had better perfusion recovery than a strain with no upregulation after HLI. Immunofluorescent staining of ischemic hindlimb tissue showed IL-21R expression on endothelial cells (ECs) from C57BL/6 mice. An EC-enriched fraction isolated from ischemic hindlimb muscle showed higher Il-21R levels than an EC-enriched fraction from nonischemic limbs. In vitro, human umbilical vein ECs showed elevated IL-21R expression after hypoxia and serum starvation. Under these conditions, IL-21 treatment increased cell viability, decreased cell apoptosis, and augmented tube formation. In vivo, either knockout Il21r or blocking IL-21 signaling by treating with IL-21R-Fc (fusion protein that blocks IL-21 binding to its receptor) in C57BL/6 mice resulted in less perfusion recovery after HLI. Both in vitro and in vivo modulation of the IL-21/IL-21R axis under hypoxic conditions resulted in increased signal transducer and activator of transcription 3 phosphorylation and a subsequent increase in the B-cell lymphoma leukemia-2/BCL-2–associated X protein ratio. Conclusion—: Our data indicate that IL-21R upregulation and ligand activation in hypoxic ECs may help perfusion recovery by limiting/preventing apoptosis and favoring cell survival and angiogenesis through the signal transducer and activator of transcription 3 pathway.

19 January 2025 in Exploration of Medicine
Verified
Journal Article
Open access
PDF file
AVAlejandra Vargas
Alejandra Vargas
BRBenjamin L. Robinson
Benjamin L. Robinson
KHKevin Houston
Kevin Houston
ASAna Rosa Vilela Sangay
Ana Rosa Vilela Sangay
MSMichael Saadeh
Michael Saadeh
DJDavid Johnson
David Johnson
The gut microbiota, a complex ecosystem of microorganisms, plays an essential role in maintaining immune and metabolic homeostasis. Disruption of this microbial balance, known as dysbiosis, has been increasingly implicated in the pathogenesis of chronic inflammatory conditions, including cardiovascular, gastrointestinal, and autoimmune diseases, as well as metabolic disorders such as diabetes and obesity. A crucial mechanism through which the gut microbiota exerts its effects on host physiology is via the production of bioactive metabolites. These metabolites, including short-chain fatty acids, bile acids, and tryptophan derivatives, are key in modulating immune responses and regulating metabolic functions. Dysbiosis disrupts the production and function of these metabolites, thereby contributing to immune dysregulation, chronic inflammation, and disease progression. This review examines the role of gut microbiota-derived metabolites in chronic inflammatory diseases, with a focus on their immunomodulatory and metabolic effects. A deeper understanding of these mechanisms may open the way for novel therapeutic strategies aimed at restoring immune homeostasis and mitigating the global burden of chronic inflammatory diseases.

24 December 2015 in Vascular Medicine
Verified
Journal Article
Open access
PDF file
TWTao Wang
Tao Wang
ACAlexis Cunningham
Alexis Cunningham
KHKevin Houston
Kevin Houston
ASAditya M Sharma
Aditya M Sharma
LCLingdan Chen
Lingdan Chen
BABrian H Annex
Brian H Annex
In most patients with symptomatic peripheral artery disease (PAD), severe stenosis in or occlusion of the major blood vessels that supply the legs make the amount of distal blood flow dependent on the capacity to induce angiogenesis and collateral vessel formation. Currently, there are no medications that improve perfusion to the ischemic limb, and thus directly treat the primary problem of PAD. A recent report from our group in a pre-clinical mouse PAD model showed that interleukin-21 receptor (IL-21R) is up-regulated in the endothelial cells from ischemic hindlimb muscle. We further showed that loss of IL-21R resulted in impaired perfusion recovery in this model. In our study, we sought to determine whether IL-21R is present in the endothelium from ischemic muscle of patients with PAD. Using human gastrocnemius muscle biopsies, we found increased levels of IL-21R in the skeletal muscle endothelial cells of patients with PAD compared to control individuals. Interestingly, PAD patients had approximately 1.7-fold higher levels of circulating IL-21. These data provide direct evidence that the IL-21R pathway is indeed up-regulated in patients with PAD. This pathway may serve as a therapeutic target for modulation.

28 February 2024 in Exploration of Immunology
Verified
Journal Article
Open access
PDF file
LCLindsey B. Cundra
Lindsey B. Cundra
MVManasa Vallabhaneni
Manasa Vallabhaneni
KHKevin Houston
Kevin Houston
MSMichael Saadeh
Michael Saadeh
AVAlejandra Vargas
Alejandra Vargas
DJDavid Johnson
David Johnson
The intestinal mucosal barrier plays a critical role in maintaining the integrity of the gastrointestinal (GI) tract and protecting the body from harmful toxins and pathogens. Nutrition additionally

12 October 2023 in Journal of Liver Transplantation
Verified
Journal Article
Open access
AAA Asgharpour
A Asgharpour
RSRk Sterling
Rk Sterling
ESE Smirnova
E Smirnova
NDN Duong
N Duong
KHK Houston
K Houston
DBD Bruno
D Bruno

23 May 2024 in Liver Transplantation
Verified
Journal Article
Closed access
KHKevin Houston
Kevin Houston
NDNikki Duong
Nikki Duong
RSRichard K. Sterling
Richard K. Sterling
AAAmon Asgharpour
Amon Asgharpour
SBSheila Bullock
Sheila Bullock
DBDavid Bruno
David Bruno
Background & Aims: The Sustained Alcohol use post-Liver Transplant (SALT) and the High-Risk Alcohol Relapse (HRAR) scores were developed to predict return to alcohol use after liver transplant (LT) for alcohol associated liver disease (ALD). Methods: A retrospective analysis of deceased donor LT 10/2018 to 4/2022 was performed. All patients (pts) underwent careful pre-LT psychosocial evaluation. Data on alcohol use, substance abuse, prior rehabilitation, and legal issues were collected. Post-LT, all were encouraged to participate in rehabilitation programs and underwent interval phosphatidylethanol (PeTH) testing. Pts with ALD were stratified by < or > 6 month sobriety prior to listing. Those with <6 month were further stratified as acute alcoholic hepatitis (AH) by NIAAA criteria and non-AH. The primary outcome was utility of the SALT (<5 vs. ≥5) and HRAR (<3 vs. ≥3) scores to predict return to alcohol use (+PeTH) within 1 year after LT. Results: Of the 365 LT, 86 had > 6 month sobriety and 85 had <6 month sobriety; 41 with AH and 44 non-AH. In those with AH, the mean time of abstinence to LT was 58 days, and 71% failed prior rehabilitation. Following LT, return to drinking was similar in the AH (24%) compared to 6M ALD (22%). Only 4% had returned to heavy drinking. The accuracy of both the SALT and HRAR scores to predict return to alcohol was low (accuracy 61-63%) with poor sensitivity (46% and 37%), specificity (67-68%), positive predictive value (22-26%) with moderate negative predictive value (NPV) (81-83%), respectively with higher NPVs (95%) in predicting return to heavy drinking. Conclusions: Both SALT and HRAR scores had good NPV in identifying patients at low risk for recidivism. Export